Merck

The present research work summarises the development of an in situ gelling ophthalmic nanoemulsion of brinzolamide providing sustained release and...

The need to improve the solubility of active pharmaceutical ingredients (APIs) has been rising for decades. Today, this need is...

Purpose: Novel tablet coating approaches include the development of continuous coating technologies. This requires a high level of automation to...

Purpose: Polyvinyl alcohol (PVA) is a well-established polymer for film coating. PVA is a synthetic, bio-compatible and toxicologically well characterized...

Epilepsy is a brain disorder that affects millions of people worldwide and is usually managed using currently available antiepileptic drugs,...

Mesoporous silica has emerged as an enabling formulation for poorly soluble active pharmaceutical ingredients (APIs). Unlike other formulations, mesoporous silica...

  Amorphous formulation technologies to improve oral absorption of poorly soluble active pharmaceutical ingredients (APIs) have become increasingly prevalent. Currently,...

The Challenges of Determining Excipient Quality In the past years, the critical role of excipients in drug production has come...

The aim of this study was to solidify a ticagrelor loaded self-microemulsifying drug delivery system (TCG-SM) with enhanced dissolution and...

Acetyl tributyl citrate (ATBC) is an (the Food and Drug Administration) FDA-approved substance for use as a pharmaceutical excipient. It...